Related Experiment Video
Updated: Jun 15, 2026
09:48
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Insulin resistance, adipose depots and gut: interactions and pathological implications
Amalia Gastaldelli1, Andrea Natali, Roberto Vettor
1Institute of Clinical Physiology, Stable Isotope Laboratory, CNR-National Research Council, Pisa, Italy. amalia@ifc.cnr.it
Summary
Insulin resistance, a complex condition influenced by genetics and lifestyle, impacts muscle, liver, and fat tissue metabolism. Obesity and ectopic fat accumulation exacerbate insulin resistance, affecting glucose metabolism and energy balance.
Area of Science:
- Metabolic pathways and endocrinology.
- Pathogenesis of metabolic disorders.
- Impact of lifestyle on human health.
Background:
- Insulin plays a crucial role in regulating metabolism across key organs: muscle, liver, and adipose tissue.
- Insulin resistance is a complex condition arising from interactions between genetic and environmental factors.
- Obesity, particularly abdominal obesity, is a well-established risk factor for developing insulin resistance.
Purpose of the Study:
- To review the metabolic actions of insulin in muscle, liver, and adipose tissue.
- To evaluate the impact of obesity and ectopic fat accumulation on insulin resistance in target organs.
- To discuss the roles of the gut microbiome and bile acids in energy balance and glucose metabolism.
Main Methods:
- Literature review focusing on insulin's metabolic actions.
- Analysis of pathogenetic mechanisms underlying insulin resistance.
- Evaluation of the influence of obesity and ectopic fat on insulin sensitivity.
Main Results:
- Obesity and ectopic fat accumulation (visceral and hepatic) significantly contribute to insulin resistance in muscle, liver, and adipose tissue.
- Sedentary lifestyles and high-fat diets are key environmental factors interacting with genetic predispositions.
- The gut microbiome and bile acids emerge as potential determinants of energy balance and glucose homeostasis.
Conclusions:
- Insulin resistance is multifactorial, involving intricate interactions between genetic susceptibility, lifestyle, and obesity.
- Targeting obesity and ectopic fat may be crucial for managing insulin resistance.
- Further research into the gut-liver axis is warranted to understand its role in metabolic health.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...